About Us

Founded in 2018, Rinri Therapeutics Ltd. is a therapeutic discovery and development company working in the field of hearing loss supported by Boehringer Ingelheim Venture Fund and UCB Ventures, BioCity and The University of Sheffield.

Rinri Therapeutics has been founded on pioneering research into auditory stem cells led by Professor Marcelo Rivolta at the University of Sheffield.

The Company has a team of experienced management, strong academic pedigree and excellent potential for clinical development.

Latest News